Your browser doesn't support javascript.
loading
Rewiring ERBB3 and ERK signaling confers resistance to FGFR1 inhibition in gastrointestinal cancer harbored an ERBB3-E928G mutation.
Yang, Xiang; Wang, Hongxiao; Xie, Enjun; Tang, Biyao; Mu, Qingdian; Song, Zijun; Chen, Junyi; Wang, Fudi; Min, Junxia.
Afiliação
  • Yang X; The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, 310058, China.
  • Wang H; The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, 310058, China.
  • Xie E; The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, 310058, China.
  • Tang B; The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, 310058, China.
  • Mu Q; The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, 310058, China.
  • Song Z; The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, 310058, China.
  • Chen J; The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, 310058, China.
  • Wang F; The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, 310058, China.
  • Min J; The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, 310058, China. junxiamin@zju.edu.cn.
Protein Cell ; 11(12): 915-920, 2020 12.
Article em En | MEDLINE | ID: mdl-32632529

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Mutação de Sentido Incorreto / Receptor ErbB-3 / Sistema de Sinalização das MAP Quinases / Receptor Tipo 1 de Fator de Crescimento de Fibroblastos / Neoplasias Gastrointestinais / Antineoplásicos Limite: Humans Idioma: En Revista: Protein Cell Assunto da revista: BIOQUIMICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Mutação de Sentido Incorreto / Receptor ErbB-3 / Sistema de Sinalização das MAP Quinases / Receptor Tipo 1 de Fator de Crescimento de Fibroblastos / Neoplasias Gastrointestinais / Antineoplásicos Limite: Humans Idioma: En Revista: Protein Cell Assunto da revista: BIOQUIMICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China